Jul 30, 2024 | Dietary Supplements, FDA and USDA Regulatory Update
9 Out Of 10 American Adults Support Listing Requirements For Dietary Supplements WASHINGTON – U.S. Senate Majority Whip Dick Durbin (D-IL) today introduced the Dietary Supplement Listing Act of 2024, legislation to require dietary supplement manufacturers to list...
Jun 28, 2024 | Dietary Supplements, FDA and USDA Regulatory Update, Foods
Earlier this year, the FDA released the draft and final guidance topics that are a priority for the agency’s Foods Program to complete during 2024. Since January, the FDA has issued the following guidances that were on the list: New Dietary Ingredient (NDI)...
Jun 17, 2024 | Cosmetics, Dietary Supplements, Drugs, Foods, Issue of the Month
Product Claim Substantiation By Jay Ansell, EAS Independent Consultant Substantiating a product claim is required by U.S. law and can help brands avoid regulatory action or provide an effective defense in litigation. For example, in April 2023, the US Federal Trade...
Apr 3, 2024 | Dietary Supplements, FDA and USDA Regulatory Update
Today, the U.S. Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry titled “New Dietary Ingredient Notification Master Files for Dietary Supplements.” This draft guidance responds to the dietary supplement industry’s...
Mar 5, 2024 | Dietary Supplements, FDA and USDA Regulatory Update
The FDA recently announced final guidance for industry on “Dietary Supplements: New Dietary Ingredient Notification Procedures and Timeframes.” This guidance is intended to help manufacturers and distributors of new dietary ingredients (NDIs) and dietary supplements...
Apr 5, 2023 | Dietary Supplements, Issue of the Month
By Paula Brock, Ph.D., MSCI, EAS Independent Consultant It is required in the United States that manufacturers and other advertisers of dietary supplements such as distributors, retailers, and endorsers, have adequate substantiation that the claims made about their...
